Related Experiment Video
Updated: May 26, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Atrial fibrillation in 2011: Stroke prevention in AF
1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham B18 7QH, UK. g.y.h.lip@bham.ac.uk
Abstract:
In 2011, key trials with oral factor Xa inhibitors in patients with atrial fibrillation highlighted promising data on these novel anticoagulants. Patients with ≥ 1 stroke risk factors can be considered for oral anticoagulation. These novel, fixed-dose drugs are given without monitoring, so clinicians must learn to balance stroke and bleeding risks.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
Atherosclerosis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

